Are peptides legal in Australia? Where each peptide stands in 2026
By the register desk · Updated
In short
Some are, on prescription, and many are not. Most peptides people ask about, including BPC-157, TB-500, CJC-1295 and ipamorelin, are Schedule 4 prescription-only medicines that are also listed in Appendix D of the Poisons Standard, which makes possessing them without authority illegal, and none has an approved product on the ARTG. Approved peptide medicines such as semaglutide and tirzepatide are lawful when a doctor prescribes them and a pharmacist dispenses them. If you already have a vial and want to know what is in it, an identity and purity test can tell you; it does not change the legal position.
Whether a peptide is legal in Australia depends on which peptide it is and what you are doing with it: possessing it, importing it or supplying it. A peptide medicine that is on the Australian Register of Therapeutic Goods (ARTG), such as semaglutide, is lawful to use when it is prescribed and dispensed; most of the injectable peptides marketed online are unapproved goods that cannot lawfully be supplied here, and many are named in the Poisons Standard as substances nobody may hold without authority.
Three bodies of rules do most of the work. The Therapeutic Goods Act 1989 requires peptide products used for a therapeutic purpose to be on the ARTG before they are imported, manufactured, supplied or advertised, unless an exemption applies (TGA). The Poisons Standard sorts substances into schedules, and the states and territories give those schedules force through their own laws. The WADA Prohibited List decides what an athlete can be sanctioned for, which is a separate question from what is lawful.
The register below sets out, for each peptide Australians search for, its Poisons Standard entry, whether any product is on the ARTG and its 2026 anti-doping status, with a link to the source for every cell. It was checked against the October 2026 edition of the Poisons Standard on 5 November 2026.
Parliament House, Canberra. The Poisons Standard is made by a delegate of the Health Secretary and is not disallowable by Parliament; the states and territories give it force. Photo: Thennicke, Wikimedia Commons, CC BY-SA 4.0.
S4 Schedule 4, prescription onlyApp D cl.5 possession without authority illegalNot named not named in the standardOn ARTG / Not on ARTG Australian Register of Therapeutic GoodsWADA S2 banned in sport at all timesMonitored WADA Monitoring Program
Checked 5 November 2026 against the Poisons Standard October 2026, ARTG searches and the WADA 2026 Prohibited List. Rows we could not verify from a primary or regulator source are left out.
Peptide
Poisons Standard (Oct 2026)
ARTG
WADA 2026
Sources
BPC-157 Body protection compound 157
S4App D cl.5
Prescription only. Must not be possessed without authority. In the standard since 1 June 2024.
Not on ARTG
No approved product (Sport Integrity Australia).
WADA S0
Named as a non-approved substance; banned at all times.
Not named. TGA: still in clinical trials and not approved here or by any comparable regulator; a product outside a trial “could be a counterfeit product”.
Not on ARTG
No ARTG result (search 5 Nov 2026).
Not named
Sport Integrity Australia: “not listed on the Prohibited List”.
Reading a row. Schedule 4 means a prescription-only medicine. Appendix D, clause 5 of the standard lists poisons that “must not be possessed by a person without authority (for example, possession other than in accordance with a legal prescription)”. A peptide can be in Schedule 4 without any product being approved: BPC-157 is the clearest example.
Not named does not mean legal. The TGA says peptide products are regulated as therapeutic goods under the Therapeutic Goods Act, so an unscheduled peptide sold for a health purpose still needs to be on the ARTG before it can be supplied (TGA, April 2026).
State law sits on top. The standard is applied through state and territory legislation, and the TGA notes those laws “may impose additional controls on the sale, supply and possession” of unapproved peptide products. Penalties differ between jurisdictions.
Legal information, not legal advice. The register reports what the published law and the regulators say. It cannot tell you how the law applies to your own circumstances; a lawyer in your state or territory can.
Importation scheme conditions, Customs permits for hormones, and what happens to goods that fail.
Where to check a peptide’s legal status
Seven places answer most questions about a particular peptide. The first six are the primary sources this paper works from. The seventh is for a different question, which is what is actually inside a vial someone already holds.
TGA: Australian Register of Therapeutic Goods search
Commonwealth register · free to search
The ARTG search lists the medicines, medical devices and biologicals that can lawfully be supplied in Australia, with product and consumer information where published.
A missing result tells you something: the TGA says products not included in the ARTG are generally ‘unapproved’ therapeutic goods. Search by active ingredient and by brand name, because the keyword search is broad and sensitive to spelling.
Use it for
Checking whether any product containing a peptide is approved for supply.
Legislative instrument · in force from 1 October 2026
The Poisons Standard places each substance in a schedule. Schedule 4 is prescription only, and Appendix D adds controls, including the clause 5 list of poisons that must not be possessed without authority.
Use the index at the back and search both the chemical name and the street name: ibutamoren, for example, is cross-referenced from MK-677. The standard is replaced by a new edition several times a year, so check the edition date on the copy you are reading.
Use it for
Finding the exact schedule entry and any Appendix D listing.
The TGA’s peptide hub collects its rules on importing, supplying, manufacturing and advertising peptide products, with its latest safety alerts and enforcement news.
It also explains when a peptide product is a cosmetic rather than a therapeutic good, which turns on the product’s ingredients, claims, presentation and intended use.
Use it for
Reading the regulator’s position and its recent alerts in one place.
The TGA page sets out every condition an individual must meet to import an unapproved therapeutic good for their own use or an immediate family member’s.
All conditions must be met. For a prescription-only medicine that includes holding a valid Australian prescription or written authority at the time of import, and the TGA says electronic prescriptions cannot be accepted for this purpose.
Use it for
Understanding what the scheme allows and what it never allows.
The ABF’s guide covers which medicines and substances can be brought into Australia and which need permission before you travel.
Import permits for anabolic substances and certain hormones come from the Office of Drug Control, which says they are needed for each shipment and for each substance.
Analytical testing service · Australian samples only
Peptide Testing Australia (peptidetesting.au) is an Australian service that tests peptide samples posted from within Australia for identity and purity, using HPLC and mass spectrometry through accredited laboratory partners, and issues a plain-English Certificate of Analysis for each vial.
A test does not change a substance’s legal status; it answers a different question, which is what the vial contains. That question is not academic: in September 2026 the TGA reported that a vial sold as retatrutide held semaglutide and no retatrutide (TGA). Testing costs A$575 per vial including GST, with periodic discounts, and extra vials in the same order are 10% off. Turnaround is about 5 to 7 business days plus postage. The service does not sell or source peptides and gives no medical advice.
Use it for
Someone who already holds a vial and wants to know what is in it.
Possession, import and supply are three separate questions
Most confusion about peptide law comes from treating “is it legal?” as one question. It is at least three, and different laws and agencies answer each one.
Three questions, three sets of rules. Diagram: Are Peptides Legal?
Possession is mostly a state and territory matter. The Poisons Standard is a list of recommendations that each jurisdiction adopts; the explanatory statement to the June 2024 edition says the states and territories regulate scheduled substances “by electing to apply the current Poisons Standard as a law within their own jurisdiction” (explanatory statement). For the peptides in Appendix D, clause 5, the standard’s own wording is that they must not be possessed without authority.
Import runs through Commonwealth law. Unapproved therapeutic goods can come in only under an exemption, most often the Personal Importation Scheme, and some hormones, including human chorionic gonadotrophin and growth hormones, also need written permission under Schedule 7A of the Customs (Prohibited Imports) Regulations.
Supply is the main target of the Therapeutic Goods Act’s penalties. Selling, giving away or advertising an unapproved peptide breaches the Therapeutic Goods Act unless an exemption applies, and the TGA says penalties include civil penalties of up to $1.82 million per breach for an individual and $18.2 million for a corporation, and criminal penalties of up to seven years’ imprisonment (TGA, September 2026).
What Schedule 4 and Appendix D mean in practice
The Poisons Standard describes Schedule 4 substances as those whose use or supply “should be by or on the order of persons permitted by State or Territory legislation to prescribe and should be available from a pharmacist on prescription”. In plain terms: a doctor’s prescription, filled at a pharmacy.
Where the register’s peptides sit. Source: Poisons Standard, October 2026.
Appendix D adds controls for particular Schedule 4 and 8 substances. Clause 5 is the one that matters for peptides: it lists 41 items that “must not be possessed by a person without authority”. They include anabolic and androgenic steroidal agents, BPC-157, CJC-1295, ipamorelin, hexarelin, GHRP-6, pralmorelin (GHRP-2), ibutamoren, TB-500 and thymosin beta 4, plus group entries for growth hormone releasing hormones, growth hormone releasing peptides and growth hormone secretagogues “including those separately specified in Schedule 4” (Poisons Standard, Appendix D).
Semaglutide, tirzepatide, melanotan II and human chorionic gonadotrophin are in Schedule 4 but not in Appendix D, clause 5. That does not make them available without a prescription; it means the extra possession control in clause 5 does not attach to them in the national standard.
Not named is not the same as legal
Several peptides people search for, including retatrutide, bremelanotide (PT-141) and GHK-Cu, do not appear by name in the October 2026 Poisons Standard. That gap is often misread online as “legal”.
It is not. The TGA’s position is that peptide products promoted or used for a therapeutic purpose, such as to influence a physiological process in the body, are therapeutic goods, and therapeutic goods must be included in the ARTG before they can be imported, manufactured, supplied, exported or advertised, with limited exceptions (TGA). An unscheduled peptide sold for weight loss or recovery is still an unapproved therapeutic good.
The standard also uses group entries “to deal with any members of the group or class that may have escaped attention but should be scheduled”, in the words of its reader’s guide. Whether a particular unnamed peptide falls within a group entry is a legal question this paper does not answer for you; where a regulator has said how an unnamed peptide is treated, the register quotes it.
The one real carve-out is cosmetics. The TGA says some peptide products may be regulated as cosmetics rather than therapeutic goods “if their ingredients, claims, presentation and intended use are limited to cosmetic purposes” (TGA peptide hub). A face cream containing a copper peptide and an injectable vial of GHK-Cu are treated very differently.
Why ‘research use only’ changes nothing
Many peptide vials are labelled “research use only” or “not for human consumption”. The TGA has said in terms that these disclaimers “do not change whether a product is regulated as a therapeutic good” and “do not remove advertising, manufacture, import, export or supply obligations” (TGA).
Its April 2026 advisory adds that such a disclaimer alone does not permit importation, and that products “identified only by codes, or those that do not clearly state the active ingredient, strength or dosage” cannot be assessed under the Personal Importation Scheme “and will not be considered for release” (TGA advisory).
“The biggest risks with unapproved peptide products are not knowing what is in the vial, how much of or even what substance it contains, whether it is sterile, or whether it contains other contaminants or toxins.” Professor Robyn Langham AM, TGA Chief Medical Adviser, September 2026.
What the TGA has done about peptides in 2026
Peptides have been a stated compliance priority for the regulator this year. The TGA says it is “prioritising compliance action against entities involved in the unlawful importation, manufacture, advertising and supply of unapproved peptide products” (TGA). The public record so far:
Date
What the TGA published
13 April 2026
Safety advisory on responsibilities when importing, compounding and supplying unapproved peptide products, naming BPC-157, GHK-Cu, TB-500, retatrutide and CJC-1295 as examples (advisory).
7 May 2026
Warning to consumers about the risks of importing and using unapproved peptide products promoted online (TGA peptide hub).
17 August 2026
Melanotan II alert: 27 infringement notices totalling $101,412 issued to a NSW-based individual for alleged unlawful supply, paid in May 2026 (alert). The same day, the TGA reported seizing more than $120,000 of illicit peptide and anabolic steroid products from two residential premises in NSW, with NSW Police.
14 September 2026
Counterfeit retatrutide alert after a serious adverse event; the vial held undeclared semaglutide at about eight times the level in ARTG-listed semaglutide products (alert).
28 September 2026
Federal Court proceedings started against BioV8 (now in liquidation) and its former directors over alleged unlawful advertising of prescription-only products, including peptides (TGA peptide hub).
The live regulation wire at the top of this page carries new TGA, WADA and health-policy headlines as they are published.
If you already have a vial
The register answers what the law says. It cannot answer what a particular vial contains, and the TGA’s own testing shows the two can be far apart: the September 2026 retatrutide case involved a product that contained a different drug altogether.
For anyone who already has a vial and wants to know what’s in it, Peptide Testing Australia tests vials posted from within Australia for identity and purity and reports the result as a Certificate of Analysis. Testing a sample does not make it lawful to possess, use or supply, and it is not medical advice; if you have taken a product and feel unwell, the TGA asks people to see a health practitioner and to report the adverse event.
How this register is kept
Every cell in the register comes from a primary or regulator source: the current edition of the Poisons Standard on the Federal Register of Legislation, ARTG searches, the WADA Prohibited List, and the TGA’s and Sport Integrity Australia’s published pages. Where we could not verify a peptide’s position from one of those sources, we left the row out rather than guess.
The register is re-checked when a new edition of the Poisons Standard commences, when WADA publishes its annual list, and when the TGA issues an alert about a peptide. The date at the top of the table is the date of the last full check. Errors can be reported to the desk; how corrections are handled is set out on the masthead page.
Questions readers ask
Are peptides legal in Australia?
Approved peptide medicines such as semaglutide and tirzepatide are legal when prescribed by a doctor and dispensed by a pharmacist. Most peptides sold online as research chemicals are unapproved, cannot lawfully be supplied, and several, including BPC-157, TB-500, CJC-1295 and ipamorelin, are listed in Appendix D of the Poisons Standard as substances that must not be possessed without authority.
Is it illegal to possess peptides?
For the peptides in Appendix D, clause 5 of the Poisons Standard, yes, unless you have authority such as a legal prescription. Possession is enforced under state and territory law, which applies the standard and can add its own controls, so penalties differ by jurisdiction (TGA).
What peptides can you buy over the counter?
None of the injectable peptides in the register can lawfully be bought without a prescription: each is either a Schedule 4 prescription-only medicine or an unapproved therapeutic good. Peptide ingredients in skin-care products are a separate case; the TGA says a peptide product can be regulated as a cosmetic if its ingredients, claims, presentation and intended use are limited to cosmetic purposes (TGA).
Will peptides fail a drug test?
In sport, many can. WADA bans peptide hormones and growth hormone releasing factors under S2 and names BPC-157 under S0, and Sport Integrity Australia lists BPC-157, CJC-1295, GHRP-6, ipamorelin and thymosin beta-4 among substances that have led to positive tests and sanctions (Sport Integrity Australia). Whether a non-sport test detects a peptide depends on what that test is designed to find.
Can I take peptides into Australia?
Only within the law’s conditions. An unapproved therapeutic good can enter under the Personal Importation Scheme only if every condition is met, including a valid Australian prescription for a prescription-only medicine and no more than a three-month supply; some hormones, such as hCG, also need a Customs permit. Non-compliant goods can be seized and destroyed (TGA). See our report on bringing peptides into Australia.
Is BPC-157 legal in Australia?
BPC-157 has been a Schedule 4 medicine listed in Appendix D, clause 5 since 1 June 2024, so possession without authority is illegal, and there is no approved BPC-157 product on the ARTG. The full position is in our BPC-157 report.
Can a doctor prescribe an unapproved peptide?
The TGA says that in limited circumstances health practitioners may access an unapproved therapeutic good for a patient through established pathways, and only after clinically appropriate treatments on the ARTG have been considered (TGA). Sport Integrity Australia warns athletes that an exemption is unlikely to be granted for an unregistered medicine (Sport Integrity Australia).
